Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dunne

Showing results (451-460 of 473) with videos related to

Pageof 48
Sort By:
MMWR. Morbidity and Mortality Weekly Report|March 28, 2024
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024Ruth Link-Gelles, Elizabeth A K Rowley, Malini B DeSilva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2026
Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational CohortAndrew M Moon, Ted K Yanagihara, Laura A Dawson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 2, 2023
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023Ruth Link-Gelles, Zachary A Weber, Sarah E Reese, et al.
Lancet Regional Health. Americas|June 19, 2023
Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021-February 2022, VISION Network: a retrospective cohort studyKatherine Adams, John J Riddles, Elizabeth A K Rowley, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2013
Molecular understanding of atmospheric particle formation from sulfuric acid and large oxidized organic moleculesSiegfried Schobesberger, Heikki Junninen, Federico Bianchi, et al.
MMWR. Morbidity and Mortality Weekly Report|December 29, 2022
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022Mark W Tenforde, Zachary A Weber, Karthik Natarajan, et al.
Influenza and Other Respiratory Viruses|March 17, 2024
Risk of COVID-19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric DisordersMatthew E Levy, Duck-Hye Yang, Margaret M Dunne, et al.
Vaccine|July 21, 2023
Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021Peter J Embi, Matthew E Levy, Palak Patel, et al.
MMWR. Morbidity and Mortality Weekly Report|March 15, 2023
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022Mark W Tenforde, Zachary A Weber, Karthik Natarajan, et al.
MMWR. Morbidity and Mortality Weekly Report|October 20, 2022
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022Amadea Britton, Peter J Embi, Matthew E Levy, et al.
Pageof 48

Showing results (451-460 of 473) with videos related to

Sort By:
Pageof 48
MMWR. Morbidity and Mortality Weekly Report|March 28, 2024
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024Ruth Link-Gelles, Elizabeth A K Rowley, Malini B DeSilva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2026
Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational CohortAndrew M Moon, Ted K Yanagihara, Laura A Dawson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 2, 2023
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023Ruth Link-Gelles, Zachary A Weber, Sarah E Reese, et al.
Lancet Regional Health. Americas|June 19, 2023
Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021-February 2022, VISION Network: a retrospective cohort studyKatherine Adams, John J Riddles, Elizabeth A K Rowley, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2013
Molecular understanding of atmospheric particle formation from sulfuric acid and large oxidized organic moleculesSiegfried Schobesberger, Heikki Junninen, Federico Bianchi, et al.
MMWR. Morbidity and Mortality Weekly Report|December 29, 2022
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022Mark W Tenforde, Zachary A Weber, Karthik Natarajan, et al.
Influenza and Other Respiratory Viruses|March 17, 2024
Risk of COVID-19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric DisordersMatthew E Levy, Duck-Hye Yang, Margaret M Dunne, et al.
Vaccine|July 21, 2023
Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021Peter J Embi, Matthew E Levy, Palak Patel, et al.
MMWR. Morbidity and Mortality Weekly Report|March 15, 2023
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022Mark W Tenforde, Zachary A Weber, Karthik Natarajan, et al.
MMWR. Morbidity and Mortality Weekly Report|October 20, 2022
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022Amadea Britton, Peter J Embi, Matthew E Levy, et al.
Pageof 48